8-K: Palatin Technologies Faces NYSE Delisting, Pursues Appeal

Palatin Technologies, Inc. has received final notification of delisting from NYSE American due to low stock price, but intends to appeal the decision.

Summary

• Palatin Technologies, Inc. (PTN) received written notification on July 7, 2025, from NYSE American LLC that a Listing Qualifications Panel unanimously affirmed the decision to initiate delisting proceedings for its common stock.
• The delisting is primarily due to the low selling price of the company's common stock, pursuant to Sections 1003(a) and 1003(f)(v) of the NYSE American Company Guide.
• Trading of Palatin's common stock on NYSE American was suspended on May 7, 2025.
• From May 8, 2025, through June 6, 2025, the common stock traded on the Pink Market of the OTC Markets Group under the symbol PTNT.
• Since June 9, 2025, the common stock has traded on the OTCQB Market of the OTC Markets Group under the symbol PTNT.
• The company intends to exercise its right to have the full Committee for Review reconsider the Panel's decision.
• A written request for this review must be submitted within 15 calendar days of the July 7, 2025 notification.
• The appeal hearing before the full Committee for Review is expected to take place in late August or September 2025.
• Palatin is actively working to resolve the NYSE American listing deficiencies prior to the appeal hearing.

Sentiment

Score: 2

Explanation: The document reports a significant negative event (delisting from NYSE American) due to the company's low stock price, which has already led to suspension of trading and transfer to OTC markets. While the company plans to appeal, the current situation is highly unfavorable and indicates severe challenges in maintaining its public listing status.

Negatives

• NYSE American has determined Palatin Technologies is no longer suitable for listing due to the low selling price of its common stock.
• Trading of the company's common stock on NYSE American was suspended on May 7, 2025.
• The company's stock has been relegated to the Pink Market and then the OTCQB Market, which typically implies lower liquidity and investor visibility compared to a major exchange.
• A Listing Qualifications Panel unanimously affirmed the decision to initiate delisting proceedings.

Risks

• Risk of permanent delisting from NYSE American if the appeal is unsuccessful.
• Potential for reduced liquidity and investor interest due to trading on OTC markets.
• Challenges in resolving NYSE American listing deficiencies.
• Negative perception and impact on corporate reputation due to delisting.

Future Outlook

Palatin Technologies intends to exercise its right to appeal the delisting decision to the full Committee for Review of NYSE American. The company is actively working to resolve the listing deficiencies before the appeal hearing, which is anticipated to occur in late August or September 2025.

Management Comments

• The Company intends to exercise its right to have the full Committee for Review reconsider the Panels decision.
• The Company is actively working to resolve the NYSE American listing deficiencies prior to the appeal hearing before the full Committee for Review, which is expected to take place in late August or September 2025.

Industry Context

This event highlights the ongoing scrutiny by major exchanges on companies failing to meet listing standards, particularly those related to minimum stock price requirements. Companies with persistently low stock prices often face delisting, leading to a transfer to over-the-counter markets, which can impact their visibility and access to capital compared to peers maintaining exchange listings.

Legal Proceedings

• NYSE American commenced delisting proceedings against Palatin Technologies, Inc. pursuant to Sections 1003(a) and 1003(f)(v) of the NYSE American Company Guide.
• A hearing on the proposed delisting was held before a Listing Qualifications Panel on June 18, 2025.
• The company intends to appeal the Panel's decision to the full Committee for Review.

Stakeholder Impact

• Shareholders: Face reduced liquidity, potential decrease in stock value, and less visibility for their investment due to trading on OTC markets.
• Investors: May find it harder to trade shares and could lose confidence in the company's ability to maintain its listing on a major exchange.
• Company Management: Faces the challenge of resolving listing deficiencies and navigating the appeal process to restore exchange listing.

Next Steps

• Submit a written request for review by the full Committee for Review within 15 calendar days of July 7, 2025.
• Actively work to resolve NYSE American listing deficiencies.
• Attend the appeal hearing before the full Committee for Review, expected in late August or September 2025.

Key Dates

Recommendation

Keywords

Palatin Technologies, PTN, NYSE American, delisting, OTC Markets, OTCQB, stock listing, listing standards, SEC filing, 8-K, corporate governance